Hospitals have not seen decreases in prices of Valeant heart medications

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Some of the top heart hospitals in the country have not received price breaks on two drugs manufactured by Valeant Pharmaceuticals, the New York Times reports. 

Valeant testified in front of Congress on May 4 and said it would offer hospitals as much as a 30 percent discount on nitropress and isuprel, two commonly prescribed medications for heart patients. However, administrators at the Cleveland Clinic, Mayo Clinic, Johns Hopkins and New York-Presbyterian told the New York Times that the prices of the expensive medications have not changed.

Read more at the link below: